Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma

Haiyue Chen, Zhenlong Zheng, Ki Yeol Kim, Xuemei Jin, MiRyung Roh, Zhehu Jin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

As a crucial antioxidant enzyme, glutathione peroxidase 3 (GPX3) has been found to be frequently repressed in many cancers due to promoter hypermethylation and is known as a possible tumor suppressor gene. In the present study, we investigated whether promoter hypermethylation of GPX3 and its repression are present in melanoma and, if so, whether GPX3 downregulation is implicated in the pathogenesis of melanoma. Our results revealed methylation of GPX3 and downregulation of its expression in both melanoma cell lines and surgical melanoma tissue samples. In melanoma cell lines, GPX3 expression was restored by treatment with 5-aza-2'-deoxycytidine both in mRNA and protein levels. Depletion of GPX3 was found to increase the proliferative ability, motility, and invasiveness of melanoma cells. Moreover, negative expression of GPX3 was related to poor prognosis in melanoma patients. These results suggest that methylation-mediated GPX3 repression may have critical implications for melanoma pathogenesis.

Original languageEnglish
Pages (from-to)2737-2744
Number of pages8
JournalOncology Reports
Volume36
Issue number5
DOIs
Publication statusPublished - 2016 Nov 1

Fingerprint

Glutathione Peroxidase
Melanoma
Down-Regulation
decitabine
Methylation
Cell Line
Tumor Suppressor Genes
Antioxidants
Messenger RNA
Enzymes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Chen, Haiyue ; Zheng, Zhenlong ; Kim, Ki Yeol ; Jin, Xuemei ; Roh, MiRyung ; Jin, Zhehu. / Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma. In: Oncology Reports. 2016 ; Vol. 36, No. 5. pp. 2737-2744.
@article{cff315f6b6e24f7ea0ca08d013555175,
title = "Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma",
abstract = "As a crucial antioxidant enzyme, glutathione peroxidase 3 (GPX3) has been found to be frequently repressed in many cancers due to promoter hypermethylation and is known as a possible tumor suppressor gene. In the present study, we investigated whether promoter hypermethylation of GPX3 and its repression are present in melanoma and, if so, whether GPX3 downregulation is implicated in the pathogenesis of melanoma. Our results revealed methylation of GPX3 and downregulation of its expression in both melanoma cell lines and surgical melanoma tissue samples. In melanoma cell lines, GPX3 expression was restored by treatment with 5-aza-2'-deoxycytidine both in mRNA and protein levels. Depletion of GPX3 was found to increase the proliferative ability, motility, and invasiveness of melanoma cells. Moreover, negative expression of GPX3 was related to poor prognosis in melanoma patients. These results suggest that methylation-mediated GPX3 repression may have critical implications for melanoma pathogenesis.",
author = "Haiyue Chen and Zhenlong Zheng and Kim, {Ki Yeol} and Xuemei Jin and MiRyung Roh and Zhehu Jin",
year = "2016",
month = "11",
day = "1",
doi = "10.3892/or.2016.5071",
language = "English",
volume = "36",
pages = "2737--2744",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "5",

}

Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma. / Chen, Haiyue; Zheng, Zhenlong; Kim, Ki Yeol; Jin, Xuemei; Roh, MiRyung; Jin, Zhehu.

In: Oncology Reports, Vol. 36, No. 5, 01.11.2016, p. 2737-2744.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma

AU - Chen, Haiyue

AU - Zheng, Zhenlong

AU - Kim, Ki Yeol

AU - Jin, Xuemei

AU - Roh, MiRyung

AU - Jin, Zhehu

PY - 2016/11/1

Y1 - 2016/11/1

N2 - As a crucial antioxidant enzyme, glutathione peroxidase 3 (GPX3) has been found to be frequently repressed in many cancers due to promoter hypermethylation and is known as a possible tumor suppressor gene. In the present study, we investigated whether promoter hypermethylation of GPX3 and its repression are present in melanoma and, if so, whether GPX3 downregulation is implicated in the pathogenesis of melanoma. Our results revealed methylation of GPX3 and downregulation of its expression in both melanoma cell lines and surgical melanoma tissue samples. In melanoma cell lines, GPX3 expression was restored by treatment with 5-aza-2'-deoxycytidine both in mRNA and protein levels. Depletion of GPX3 was found to increase the proliferative ability, motility, and invasiveness of melanoma cells. Moreover, negative expression of GPX3 was related to poor prognosis in melanoma patients. These results suggest that methylation-mediated GPX3 repression may have critical implications for melanoma pathogenesis.

AB - As a crucial antioxidant enzyme, glutathione peroxidase 3 (GPX3) has been found to be frequently repressed in many cancers due to promoter hypermethylation and is known as a possible tumor suppressor gene. In the present study, we investigated whether promoter hypermethylation of GPX3 and its repression are present in melanoma and, if so, whether GPX3 downregulation is implicated in the pathogenesis of melanoma. Our results revealed methylation of GPX3 and downregulation of its expression in both melanoma cell lines and surgical melanoma tissue samples. In melanoma cell lines, GPX3 expression was restored by treatment with 5-aza-2'-deoxycytidine both in mRNA and protein levels. Depletion of GPX3 was found to increase the proliferative ability, motility, and invasiveness of melanoma cells. Moreover, negative expression of GPX3 was related to poor prognosis in melanoma patients. These results suggest that methylation-mediated GPX3 repression may have critical implications for melanoma pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84989904808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989904808&partnerID=8YFLogxK

U2 - 10.3892/or.2016.5071

DO - 10.3892/or.2016.5071

M3 - Article

VL - 36

SP - 2737

EP - 2744

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 5

ER -